skip to main content

IBD azathioprine monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateGastrointestinal TherapeuticsIBD azathioprine monitoringGPhC CRA

A patient with Crohn's disease starts azathioprine and asks why they need frequent blood tests. They feel well. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CFull blood count and liver function monitoring according to protocol

Azathioprine can cause bone marrow suppression and hepatotoxicity. The best answer addresses the key safety, legal or pharmaceutical care issue in the vignette. The other options would either delay appropriate care, create a new risk, or fail to resolve the issue. This is consistent with the cited UK reference for safe pharmacy practice.

Reference: BNF; NICE CKS